Drug intelligence / Profile preview

granufink

Development stage
Unknown
Lead developer
Omega Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Granufink is a line of herbal medicinal products primarily used for the treatment of lower urinary tract symptoms (LUTS) and bladder complaints. The most common formulations include Granufink Prosta forte 500 mg and Granufink Prosta plus Sabal. These products are based on plant-derived active ingredients such as thick extract from pumpkin seeds (Cucurbita pepo), sometimes combined with saw palmetto fruit dry extract (Serenoa repens) or other botanicals like hop cones and fragrant sumac bark in specific variants. The mechanism of action is not fully elucidated but is believed to involve anti-inflammatory effects, modulation of bladder function, and support for prostate health through phytosterols and fatty acids present in the extracts. Granufink products are marketed as traditional herbal medicines registered based on long-standing use rather than clinical trial data equivalent to pharmaceuticals. They are indicated for mild to moderate urinary symptoms associated with benign prostatic hyperplasia in men or overactive bladder/bladder weakness in women[1][2][3][4][5].

Brand names
GranufinkGRANU FINKGRANU FINK Prosta forte 500 mgGRANU FINK Prosta plus SabalGRANU FINK femina
Other names
Uromedic pumpkin seed extract (for main active ingredient)Kürbissamen-Dickextrakt (German for pumpkin seed thick extract)
02

Targets

SRD5A (Steroid 5-alpha-reductase)AR (Adrenergic receptors)

Beyond the preview

Go deeper on granufink.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on granufink.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call